Complementary Services

At CDAS we have a broad array of contract research programs to study the in vivo effects of small/large molecule drugs. Briefly, these services include:

• in vivo drug properties
• Biodistribution studies
• Anticancer efficacy studies

Within our in vitro biomarker analysis capabilities at CDAS, we also offer a fully integrated range of multiple techniques including:

• qRTPCR
• Western Blot
• ELISA
• Gene array analysis
• Toxicity assays
• Flow cytometry analysis

Our programs are highly customizable and designed to facilitate the identification, validation, and analysis of biomarkers and therapeutic targets.